Latest Corporate News

Successful FDA Inspection of our Bioanalytical Laboratory

 

Pharmascience Inc. Launches (Pr)pms-NITROFURANTOIN, First Generic Bioequivalent to MacroBID® Available on the Market, for the Treatment of Urinary Tract Infections

 

Pendopharm a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals